Assessment of proxy-reported responses as predictors of motor and sensory peripheral neuropathy in children with B-lymphoblastic leukemia.
Saved in:
| Title: | Assessment of proxy-reported responses as predictors of motor and sensory peripheral neuropathy in children with B-lymphoblastic leukemia. |
|---|---|
| Authors: | Rodwin RL; Department of Pediatrics, Yale School of Medicine, New Haven, Connecticut, USA.; Yale Cancer Center, New Haven, Connecticut, USA., DelRocco NJ; Department of Biostatistics, Colleges of Medicine and Public Health & Health Professions, University of Florida, Gainesville, Florida, USA., Hibbitts E; Department of Biostatistics, Colleges of Medicine and Public Health & Health Professions, University of Florida, Gainesville, Florida, USA., Devidas M; Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Whitley MK; Department of Pediatrics, Yale School of Medicine, New Haven, Connecticut, USA., Mohrmann CE; Department of Pediatrics, Washington University School of Medicine, St. Louis Children's Hospital, St. Louis, Missouri, USA.; Goldfarb School of Nursing, St. Louis, Missouri, USA., Schore RJ; Center of Cancer and Blood Disorders, Children's National Health System, Washington, District of Columbia, USA.; George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, USA., Raetz E; Department of Pediatrics, NYU Langone Health, New York, New York, USA., Winick NJ; Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas, USA., Hunger SP; Department of Pediatrics and the Center for Childhood Cancer Research, Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA., Loh ML; Division of Pediatric Hematology, Oncology, Bone Marrow Transplant and Cellular Therapy, Seattle Children's Hospital and the Ben Towne Center for Childhood Cancer Research, University of Washington, Seattle, Washington, USA., Hockenberry MJ; Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.; School of Nursing, Duke University, Durham, North Carolina, USA., Ma X; Yale Cancer Center, New Haven, Connecticut, USA.; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut, USA.; Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven, Connecticut, USA., Angiolillo AL; Center of Cancer and Blood Disorders, Children's National Health System, Washington, District of Columbia, USA.; George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, USA.; Servier Pharmaceuticals, Boston, Massachusetts, USA., Ness KK; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Kairalla JA; Department of Biostatistics, Colleges of Medicine and Public Health & Health Professions, University of Florida, Gainesville, Florida, USA., Kadan-Lottick NS; Cancer Prevention and Control Program, Georgetown Lombardi Comprehensive Cancer Center, Washington, District of Columbia, USA. |
| Source: | Pediatric blood & cancer [Pediatr Blood Cancer] 2023 Nov; Vol. 70 (11), pp. e30634. Date of Electronic Publication: 2023 Aug 17. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: John Wiley Country of Publication: United States NLM ID: 101186624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1545-5017 (Electronic) Linking ISSN: 15455009 NLM ISO Abbreviation: Pediatr Blood Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
